~~<i id='1249ED28DD'><strike id='1249ED28DD'><tt id='1249ED28DD'><pre id='1249ED28DD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：leisure time 2025-10-01 15:27:47 - browse：6387

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： In utero gene editing: an explainer

hotspot

entertainment

explore

Wikipedia

entertainment

MollyFergusonforSTATWhatdoyousaytoapatientwhentheFDArejects“their”experimentaldrug—onethattheybeliev

WSS

What will Novo Nordisk's VC do with its influx of cash?

CDC picks Alphabet's Verily for wasterwater surveillance contract

Congress extends some pandemic preparedness programs

Ed Silverman on new gene therapies, biosimilars, coffee, and more

A solution to the after

Health insurers' Q3 question: how much care are people getting?

Wikipedia

fashion

hotspot

How to save PrEP access — and even expand it

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Cancer drug shortages should be causing more outrage

Setback for rare diseases as Taysha Gene Therapies pulls back

How to save PrEP access — and even expand it

Lawsuit highlights wrinkle for disputes over surprise medical bills

Wildfire smoke exposes gaps in outdoor worker protections

The Harvard botanist who searched for psychedelics in the Amazon

In age of alternative facts, a scholarly course on calling out crap

2023 Nobel Prize in Medicine goes to Karikó and Weissman

hotspot

Lawsuit highlights wrinkle for disputes over surprise medical bills

The stability of $0 premiums in Medicare Advantage

WHO recommends second malaria vaccine

New oral drug delivery patch is modeled after octopus tentacles

WHO recommends second malaria vaccine

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

entertainment

explore

Wikipedia

entertainment